420 with CNW — Largest Employee Union Wants End to

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
195
420 with CNW — Largest Employee Union Wants End to Testing Federal Employees for THC

For decades, federal employers have had the right to test their employees for cannabis used because of federal regulations that outlawed the cultivation, distribution and sale of marijuana. But as states have begun to legalize recreational and medical cannabis use, reform activists argued that these drug tests penalize consumers for indulging in behaviors that are considered legal in their home states.

The largest federal employee union in the country is now calling on the government to put an end to policies that punish federal workers for using cannabis during their free time. The American Federation of Government Employees (AFGE) also adopted a resolution in support of federal cannabis legalization during its 42nd national convention last month. AFGE currently represents more than 700,000 federal workers in America.

Although the union hasn’t released the final text of the measure, which is titled “Resolution to Support Deleting Responsible Off-Duty Marijuana Usage from Sustainability Criteria,” it posted the resolution on its website. According to a draft version of the measure that was obtained by Marijuana Moment, it also supports the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act.

If it becomes law, the MORE Act would remove cannabis from the list of controlled substances, eliminate penalties for federal cannabis offenses and expunge prior federal cannabis convictions from people’s records. It has advanced past the House of Representatives twice so far.

The resolution noted that cannabis use has been increasingly accepted by the American public, especially regarding cannabis use for medical purposes by veterans and civilians. This is clear by the number of states that have chosen to legalize cannabis for medical use in recent years. However, cannabis remains a controlled substance at the federal level, and the resolution says this attaches unreasonable security to cannabis usage.

As such, members of AFGE voted in favor of the measure to partner with other unions and support federal cannabis legalization as well as compel the U.S. Office of Personnel Management (OPM) to get rid of federal policies that require testing cannabis in employees who work in nonnational and nonsafety sensitive positions. AFGE requested that the OPM remove responsible off-duty cannabis use from its sustainability criteria 5 CFR § 731.202 at the state level in Washington, D.C., and other jurisdictions with medical marijuana programs.

The draft measure also urged the OPM to remove marijuana-related questions from the SF86, e-QIP, SF85 and SF8SP. These are some of the forms that people applying for certain federal government positions have to fill out. The measure came shortly after the leaders of the House Appropriations Committee urged the White House to review guidelines and policies on the firing and hiring of individuals who use cannabis privately in states with legal markets.

If these reforms are implemented, more people will feel free to try out the cannabis products made by state-legal companies such as Flora Growth Corp. (NASDAQ: FLGC) since the fear of being victimized or even losing their federal jobs would have been removed.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer


Flora Growth Corp. (FLGC) Stock Research Links

FLGC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Merck & Co., Inc. Investors Urged to Take Action Now

Updated Category News Views 131

Important Notice for Merck & Co., Inc. Investors Investors in Merck & Co., Inc. (MRK) are being encouraged to seek legal counsel as we approach a significant deadline related to a securities class action lawsuit. This timeline marks an important opportunity for purchasers of Merck's securities made between February 3, 2022, and February 3, 2025, to secure representation...

Continue Reading
Justice-Impacted Individuals Gaining Access to Education

Updated Category News Views 116

Expanding Opportunities for Justice-Impacted Individuals In a significant initiative aimed at improving the lives of justice-impacted individuals, multiple states are coming together to enhance educational and workforce pathways. This collaborative effort is focused on providing necessary resources and opportunities for individuals who have faced incarceration, aiming to...

Continue Reading
Celebrating Excellence: 2025 Lifetime Achievement Award Recipients

Updated Category News Views 123

Honoring Peter Murray and SawTeen See at the CTBUH 2025 Awards The Council on Tall Buildings and Urban Habitat (CTBUH) has recognized two remarkable figures in the field of architecture and structural engineering for their essential contributions to urban design. Peter Murray, co-founder of New London Architecture, and SawTeen See, a prominent structural engineer, are the...

Continue Reading
Northern Oil and Gas Expands Horizons with Acquisition Talks

Updated Category News Views 145

Northern Oil and Gas Options for Strategic Growth Northern Oil and Gas is actively pursuing acquisition opportunities, specifically targeting Granite Ridge Resources. Based in Minneapolis, this ambitious company has shown intent to enhance its portfolio by considering Granite Ridge, a relatively smaller player in the oil industry, skilled in extracting resources from...

Continue Reading
Invivyd Announces Insights into VYD2311's Clinical Journey

Updated Category News Views 176

Invivyd Hosts Webcast to Discuss the REVOLUTION Program Invivyd, Inc. (Nasdaq: IVVD) will present a live webcast detailing its innovative REVOLUTION clinical program. This event, aimed at both investors and the public, will showcase the company’s promising monoclonal antibody, VYD2311, which serves as a vaccine alternative for COVID-19 prevention. The Overview of...

Continue Reading